NOVO NORDISK A S (NVO) Form 6-K — Oct 13, 2026
Novo Nordisk repurchased 1,250,000 B shares for roughly DKK 251.6 million across five trading days from 5-9 October 2026 under its ongoing buyback programme. Under the programme initiated 6 May 2026, the company has now bought 23,090,000 B shares for DKK 6,758,876,433, part of an overall plan to repurchase up to DKK 15 billion of B shares in the 12 months from 4 February 2026.
Key figures
- Shares Outstanding
- 4465000000
- Ytd value dkk
- 10558876422
- Treasury shares
- 51889876
- Programme cap dkk
- 15000000000
- Repurchase window
- 6 May 2026 to 1 February 2027
- Ytd avg price dkk
- 278.97
- Ytd repurchased shares
- 37849179
- Treasury pct of share capital
- 1.2%
- Value under may programme dkk
- 6758876433
- Shares repurchased under may programme
- 23090000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.